Guishan Xiao

523 citations
11 papers · 425 indexed · h-index 8
Topics
Inflammatory mediators and NSAID effects (5 papers)Eicosanoids and Hypertension Pharmacology (3 papers)Estrogen and related hormone effects (2 papers)
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Guishan Xiao

11 papers receiving 419 citations

Peers

Guishan Xiao
Comparison fields: 5 of 65
  • Molecular Biology 230
  • Pharmacology 156
  • Genetics 90
  • Biochemistry 80
  • Cancer Research 71
Replace Takayuki Okuno with:
Takayuki Okuno Japan
Angelina M. Santini United States
Janice Darlington Türkiye
Debra K. Breuer United States
Louise Boulet Canada
Adegoke O. Adeniji United States
Shui‐Ping So United States
Ivonne Wobst Germany
Angela Styhler Canada
Efrosini Barbayianni Greece
Guishan Xiao relative to Takayuki Okuno Japan Takayuki Okuno's profile →
Citations per field
00.5×1.5×2.4×
Takayuki Okuno · 1×
Citations per year

Countries citing papers authored by Guishan Xiao

Since Specialization
Citations

This map shows the geographic impact of Guishan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guishan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guishan Xiao more than expected).

Fields of papers citing papers by Guishan Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guishan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guishan Xiao. The network helps show where Guishan Xiao may publish in the future.

Co-authorship network of co-authors of Guishan Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Guishan Xiao. A scholar is included among the top collaborators of Guishan Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guishan Xiao. Guishan Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 10
2 52
3 32
4 39
5 73
6 1
7 35
8 64
9 7
10 106
11 6

About Guishan Xiao

Guishan Xiao is a scholar working on Biochemistry, Pharmacology and Cancer Research, having authored 11 papers that have together received 425 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Biochemistry (80 citations), Pharmacology (156 citations) and Pharmacology (42 citations). Guishan Xiao has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Richard J. Kulmacz, Graham Palmer, Ah-Lim Tsai, Paul Marshall, William C. Boyar, David C. Swinney, Ah‐Lim Tsai, Wei Chen, Rongrong Zhang and Wentao Li. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026